Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Brepocitinib Tosylate [usan]
2. C960dpp15o
3. Pf-06700841-15
4. Brepocitinib Tosylate (usan)
5. Methanone, ((1s)-2,2-difluorocyclopropyl)(3-(2-((1-methyl-1h-pyrazol-4-yl)amino)-4-pyrimidinyl)-3,8-diazabicyclo(3.2.1)oct-8-yl)-, 4-methylbenzenesulfonate (1:1)
6. 2140301-96-6
7. Unii-c960dpp15o
8. Chembl4298160
9. Brepocitinib Tosylate [who-dd]
10. D11538
11. Pf-06700841 Tosylate Salt, >=98% (hplc)
12. ((1s)-2,2-difluorocyclopropyl)(3-(2-((1-methyl-1h-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo(3.2.1)octan-8-yl)methanone, 4-methylbenzenesulfonate (1:1)
| Molecular Weight | 561.6 g/mol |
|---|---|
| Molecular Formula | C25H29F2N7O4S |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 5 |
| Exact Mass | 561.19697993 g/mol |
| Monoisotopic Mass | 561.19697993 g/mol |
| Topological Polar Surface Area | 142 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 815 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
64
PharmaCompass offers a list of Brepocitinib tosylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Brepocitinib tosylate manufacturer or Brepocitinib tosylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Brepocitinib tosylate manufacturer or Brepocitinib tosylate supplier.
PharmaCompass also assists you with knowing the Brepocitinib tosylate API Price utilized in the formulation of products. Brepocitinib tosylate API Price is not always fixed or binding as the Brepocitinib tosylate Price is obtained through a variety of data sources. The Brepocitinib tosylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Brepocitinib tosylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Brepocitinib tosylate, including repackagers and relabelers. The FDA regulates Brepocitinib tosylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Brepocitinib tosylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Brepocitinib tosylate supplier is an individual or a company that provides Brepocitinib tosylate active pharmaceutical ingredient (API) or Brepocitinib tosylate finished formulations upon request. The Brepocitinib tosylate suppliers may include Brepocitinib tosylate API manufacturers, exporters, distributors and traders.
Brepocitinib tosylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Brepocitinib tosylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Brepocitinib tosylate GMP manufacturer or Brepocitinib tosylate GMP API supplier for your needs.
A Brepocitinib tosylate CoA (Certificate of Analysis) is a formal document that attests to Brepocitinib tosylate's compliance with Brepocitinib tosylate specifications and serves as a tool for batch-level quality control.
Brepocitinib tosylate CoA mostly includes findings from lab analyses of a specific batch. For each Brepocitinib tosylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Brepocitinib tosylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Brepocitinib tosylate EP), Brepocitinib tosylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Brepocitinib tosylate USP).
